Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Positive Technologies Group approved dividends for 9 months 2023

11/23/23 POSI

KAMAZ launches corporate carsharing service

11/23/23 KMAZ

TNS Energy Group may leave the stock exchange

11/23/23 TNSE

Mechel reported a performance decline in 9 months of 2023

11/23/23 MTLR

Rosseti South reported for 9 months of 2023

11/23/23 MRKY

ALMAR retains plans to conduct an IPO on SPB Exchange

11/23/23 SPBE

Dixy pilots electronic price tag technology

11/23/23 MGNT

Board of Directors of Donskoy Factory of Radiocomponents recommended dividends

11/23/23 DZRD

INARCTICA announces SPO for 4% of shares

11/23/23 AQUA

Whoosh reported for 9 months of 2023 by IFRS

11/23/23 WUSH